Brainstorm Cell Therapeutics Stock Performance
| BCLI Stock | USD 0.54 0.04 6.90% |
The firm shows a Beta (market volatility) of -0.4, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Brainstorm Cell are expected to decrease at a much lower rate. During the bear market, Brainstorm Cell is likely to outperform the market. At this point, Brainstorm Cell Ther has a negative expected return of -0.13%. Please make sure to confirm Brainstorm Cell's standard deviation, kurtosis, period momentum indicator, as well as the relationship between the maximum drawdown and day median price , to decide if Brainstorm Cell Ther performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Brainstorm Cell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's essential indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders. ...more
Last Split Factor 1:15 | Last Split Date 2024-10-01 |
1 | Understanding Brainstorm Cell Therapeutics Inc.s price movement - 2025 Trading Recap Intraday High Probability Setup Alerts - newser.com | 11/13/2025 |
2 | How Brainstorm Cell Therapeutics Inc. stock trades in high volatility - Weekly Investment Recap Community Supported Trade Ideas - Newser | 12/04/2025 |
3 | Acquisition by Chaim Lebovits of 31185 shares of Brainstorm Cell subject to Rule 16b-3 | 12/11/2025 |
4 | Weekly Earnings Is Brainstorm Cell Therapeutics Inc in a long term uptrend - 2025 Price Momentum Real-Time Volume Analysis - baoquankhu1.vn | 01/14/2026 |
5 | Acquisition by Waclawski Anthony of 80000 shares of Brainstorm Cell at 12.58 subject to Rule 16b-3 | 01/23/2026 |
6 | Whats the profit margin of Brainstorm Cell Therapeutics Inc. - Trade Entry Report Community Consensus Stock Picks - mfd.ru | 01/26/2026 |
| Begin Period Cash Flow | 1.5 M | |
| Total Cashflows From Investing Activities | 12 K |
Brainstorm | Build AI portfolio with Brainstorm Stock |
Brainstorm Cell Relative Risk vs. Return Landscape
If you would invest 63.00 in Brainstorm Cell Therapeutics on November 13, 2025 and sell it today you would lose (9.00) from holding Brainstorm Cell Therapeutics or give up 14.29% of portfolio value over 90 days. Brainstorm Cell Therapeutics is currently does not generate positive expected returns and assumes 5.0874% risk (volatility on return distribution) over the 90 days horizon. In different words, 45% of stocks are less volatile than Brainstorm, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Brainstorm Cell Target Price Odds to finish over Current Price
The tendency of Brainstorm Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.54 | 90 days | 0.54 | over 95.31 |
Based on a normal probability distribution, the odds of Brainstorm Cell to move above the current price in 90 days from now is over 95.31 (This Brainstorm Cell Therapeutics probability density function shows the probability of Brainstorm Stock to fall within a particular range of prices over 90 days) .
Brainstorm Cell Price Density |
| Price |
Predictive Modules for Brainstorm Cell
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Brainstorm Cell Ther. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Brainstorm Cell Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Brainstorm Cell is not an exception. The market had few large corrections towards the Brainstorm Cell's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Brainstorm Cell Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Brainstorm Cell within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.19 | |
β | Beta against Dow Jones | -0.4 | |
σ | Overall volatility | 0.04 | |
Ir | Information ratio | -0.06 |
Brainstorm Cell Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Brainstorm Cell for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Brainstorm Cell Ther can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Brainstorm Cell Ther generated a negative expected return over the last 90 days | |
| Brainstorm Cell Ther has high historical volatility and very poor performance | |
| Brainstorm Cell Ther has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 849 K. Net Loss for the year was (11.62 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Brainstorm Cell Therapeutics currently holds about 12.24 M in cash with (9.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34. | |
| Latest headline from news.google.com: Whats the profit margin of Brainstorm Cell Therapeutics Inc. - Trade Entry Report Community Consensus Stock Picks - mfd.ru |
Brainstorm Cell Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Brainstorm Stock often depends not only on the future outlook of the current and potential Brainstorm Cell's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Brainstorm Cell's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.3 M | |
| Cash And Short Term Investments | 187 K |
Brainstorm Cell Fundamentals Growth
Brainstorm Stock prices reflect investors' perceptions of the future prospects and financial health of Brainstorm Cell, and Brainstorm Cell fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Brainstorm Stock performance.
| Return On Equity | -11.22 | ||||
| Return On Asset | -4.0 | ||||
| Current Valuation | 6.38 M | ||||
| Shares Outstanding | 11.03 M | ||||
| Price To Earning | (16.00) X | ||||
| Price To Book | 65.82 X | ||||
| Revenue | 849 K | ||||
| EBITDA | (11.31 M) | ||||
| Net Income | (11.62 M) | ||||
| Cash And Equivalents | 12.24 M | ||||
| Cash Per Share | 0.34 X | ||||
| Total Debt | 720 K | ||||
| Debt To Equity | 0.60 % | ||||
| Current Ratio | 1.63 X | ||||
| Book Value Per Share | (0.70) X | ||||
| Cash Flow From Operations | (9.09 M) | ||||
| Earnings Per Share | (1.50) X | ||||
| Market Capitalization | 6.29 M | ||||
| Total Asset | 1.83 M | ||||
| Retained Earnings | (226.64 M) | ||||
| Working Capital | (8.59 M) | ||||
| Current Asset | 16.79 M | ||||
| Current Liabilities | 2.95 M | ||||
About Brainstorm Cell Performance
By evaluating Brainstorm Cell's fundamental ratios, stakeholders can gain valuable insights into Brainstorm Cell's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Brainstorm Cell has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Brainstorm Cell has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 5.71 | 6.00 | |
| Return On Capital Employed | 1.47 | 1.92 | |
| Return On Assets | 5.71 | 6.00 | |
| Return On Equity | (1.35) | (1.28) |
Things to note about Brainstorm Cell Ther performance evaluation
Checking the ongoing alerts about Brainstorm Cell for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Brainstorm Cell Ther help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Brainstorm Cell Ther generated a negative expected return over the last 90 days | |
| Brainstorm Cell Ther has high historical volatility and very poor performance | |
| Brainstorm Cell Ther has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 849 K. Net Loss for the year was (11.62 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Brainstorm Cell Therapeutics currently holds about 12.24 M in cash with (9.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34. | |
| Latest headline from news.google.com: Whats the profit margin of Brainstorm Cell Therapeutics Inc. - Trade Entry Report Community Consensus Stock Picks - mfd.ru |
- Analyzing Brainstorm Cell's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Brainstorm Cell's stock is overvalued or undervalued compared to its peers.
- Examining Brainstorm Cell's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Brainstorm Cell's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Brainstorm Cell's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Brainstorm Cell's stock. These opinions can provide insight into Brainstorm Cell's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Brainstorm Stock analysis
When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |